1. HMG-CoA reductase inhibitors: An exciting development in the treatment of hyperlipoproteinemia;Kathawala;Med Res Rev,1991
2. Kathawala FG Scallen T Engstrom RG Weinstein DB Schuster H Stabler R Kratunis J Wareing JR Jewell WF Widler L Wattanasin S XU 62-320, an HMG-CoA reductase inhibitor, more potent than compactin and lovastatin October 913, 1988 445
3. Engstrom RG Weinstein DB Kathawala FG Scallen T Eskesen JB Rucker ML Miserendino R Babiak J Hypolipoproteinemic activity of XU 62-320, a potent competitive inhibitor of HMG-CoA reductase October 913, 1988 230
4. Current therapy for hypercholesterolemia;Blum;JAMA,1989
5. Treatment of hyperlipidaemia;Illingworth;Br Med Bull,1990